2.34
price down icon4.10%   -0.10
after-market After Hours: 2.35 0.01 +0.43%
loading
Cassava Sciences Inc stock is traded at $2.34, with a volume of 1.16M. It is down -4.10% in the last 24 hours and down -20.41% over the past month. Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
See More
Previous Close:
$2.44
Open:
$2.4
24h Volume:
1.16M
Relative Volume:
0.22
Market Cap:
$112.58M
Revenue:
-
Net Income/Loss:
$-97.22M
P/E Ratio:
-1.6957
EPS:
-1.38
Net Cash Flow:
$-82.44M
1W Performance:
-1.68%
1M Performance:
-20.41%
6M Performance:
-92.33%
1Y Performance:
-90.11%
1-Day Range:
Value
$2.33
$2.44
1-Week Range:
Value
$2.2808
$2.49
52-Week Range:
Value
$2.23
$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Name
Name
Cassava Sciences Inc
Name
Phone
512-501-2444
Name
Address
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Name
Employee
29
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
SAVA's Discussions on Twitter

Compare SAVA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SAVA
Cassava Sciences Inc
2.34 112.58M 0 -97.22M -82.44M -1.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
481.16 123.91B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
722.07 78.94B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
657.97 39.98B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
278.25 35.89B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
119.94 28.75B 3.30B -501.07M 1.03B -2.1146

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-26-24 Downgrade H.C. Wainwright Buy → Neutral
Oct-08-24 Upgrade H.C. Wainwright Neutral → Buy
Jul-01-24 Downgrade H.C. Wainwright Buy → Neutral
Nov-16-22 Downgrade B. Riley Securities Buy → Neutral
Jul-15-21 Downgrade Cantor Fitzgerald Overweight → Neutral
Jul-07-21 Reiterated Maxim Group Buy
Apr-27-21 Initiated B. Riley Securities Buy
Feb-16-21 Reiterated H.C. Wainwright Buy
Oct-23-20 Initiated Cantor Fitzgerald Overweight
Sep-23-20 Upgrade H.C. Wainwright Neutral → Buy
May-18-20 Downgrade H.C. Wainwright Buy → Neutral
May-15-20 Downgrade Maxim Group Buy → Hold
Jan-10-20 Reiterated Maxim Group Buy
View All

Cassava Sciences Inc Stock (SAVA) Latest News

pulisher
Feb 06, 2025

Perhaps timely catching Cassava Sciences Inc (SAVA) would be a good idea - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Shareholders - GlobeNewswire Inc.

Feb 06, 2025
pulisher
Feb 06, 2025

SAVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to - The Bakersfield Californian

Feb 06, 2025
pulisher
Feb 06, 2025

Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationSAVA - PR Newswire

Feb 06, 2025
pulisher
Feb 05, 2025

Cassava terminates phase 3 REFOCUS-ALZ trial for simufilam - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire

Feb 05, 2025
pulisher
Feb 05, 2025

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Feb 05, 2025
pulisher
Feb 05, 2025

Investing in Cassava Sciences Inc (SAVA) Is Getting More Attractive - Knox Daily

Feb 05, 2025
pulisher
Feb 04, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - GlobeNewswire Inc.

Feb 04, 2025
pulisher
Feb 04, 2025

Cassava Sciences, Inc. Investors: Please contact the - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

Cassava Sciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. - The Bakersfield Californian

Feb 04, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

Cassava Sciences, Inc. Class Action: Levi & Korsinsky - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - ACCESS Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

Cassava Sciences Inc (SAVA) deserves closer scrutiny - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline - PR Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

Clear Creek Financial Management LLC Reduces Position in Cassava Sciences, Inc. (NASDAQ:SAVA) - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: - GlobeNewswire

Feb 04, 2025
pulisher
Feb 03, 2025

SAVA DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Cassava Sciences, Inc. (SAVA) Securities Fraud Class Action Lawsuit - Business Wire

Feb 03, 2025
pulisher
Feb 03, 2025

SAVA DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cassava Sciences, Inc. Investors to - The Bakersfield Californian

Feb 03, 2025
pulisher
Feb 03, 2025

2025-02-03 | Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Feb 03, 2025
pulisher
Feb 03, 2025

Looking Into Cassava Sciences's Recent Short Interest - Benzinga

Feb 03, 2025
pulisher
Feb 03, 2025

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Cassava - The Bakersfield Californian

Feb 03, 2025
pulisher
Feb 03, 2025

Shareholders of Cassava Sciences, Inc. Should Contact The Gross - GuruFocus.com

Feb 03, 2025
pulisher
Feb 02, 2025

2025-02-02 | Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Feb 02, 2025
pulisher
Feb 02, 2025

2025-02-02 | Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc.(SAVA) Shareholders | NDAQ:SAVA | Press Release - Stockhouse Publishing

Feb 02, 2025
pulisher
Feb 02, 2025

Kessler Topaz Meltzer & Check, LLP Reminds SAVA - GlobeNewswire

Feb 02, 2025
pulisher
Feb 02, 2025

2025-02-02 | Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Feb 02, 2025
pulisher
Jan 31, 2025

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - PR Newswire

Jan 31, 2025
pulisher
Jan 31, 2025

2025-01-31 | Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 31, 2025
pulisher
Jan 31, 2025

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - PrimePublishers.com

Jan 31, 2025
pulisher
Jan 31, 2025

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava - GlobeNewswire

Jan 31, 2025
pulisher
Jan 31, 2025

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel - The Bakersfield Californian

Jan 31, 2025
pulisher
Jan 31, 2025

SAVA SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc. (SAVA) - PR Newswire

Jan 31, 2025
pulisher
Jan 31, 2025

2025-01-31 | Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc. (SAVA) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 31, 2025
pulisher
Jan 31, 2025

Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - PR Newswire

Jan 31, 2025
pulisher
Jan 30, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - Marketscreener.com

Jan 30, 2025
pulisher
Jan 30, 2025

Contact Levi & Korsinsky by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc.(SAVA) - Stockhouse Publishing

Jan 30, 2025
pulisher
Jan 30, 2025

2025-01-30 | Shareholders that lost money on Cassava Sciences, Inc.(SAVA) should contact Levi & Korsinsky about pending Class ActionSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 30, 2025
pulisher
Jan 30, 2025

Class Action Filed Against Cassava Sciences, Inc. (SAVA) Seeking Recovery for InvestorsContact The Gross Law Firm - GuruFocus.com

Jan 30, 2025
pulisher
Jan 29, 2025

The Gross Law Firm Reminds Cassava Sciences, Inc. Investors - GlobeNewswire

Jan 29, 2025
pulisher
Jan 29, 2025

2025-01-29 | Cassava Sciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationSAVA | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 29, 2025
pulisher
Jan 28, 2025

2025-01-28 | Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urged to Join Class ActionContact Levi & Korsinsky to Learn More | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 28, 2025
pulisher
Jan 28, 2025

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure - The Bakersfield Californian

Jan 28, 2025
pulisher
Jan 28, 2025

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. S - GuruFocus.com

Jan 28, 2025
pulisher
Jan 28, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire

Jan 28, 2025
pulisher
Jan 28, 2025

Lead Plaintiff Deadline Approaching in SAVA: Kessler Topaz - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire

Jan 28, 2025
pulisher
Jan 27, 2025

2025-01-27 | Levi & Korsinsky Notifies Shareholders of Cassava Sciences, Inc.(SAVA) of a Class Action Lawsuit and an Upcoming Deadline | NDAQ:SAVA | Press Release - Stockhouse Publishing

Jan 27, 2025

Cassava Sciences Inc Stock (SAVA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):